Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.
about
Apigenin sensitizes prostate cancer cells to Apo2L/TRAIL by targeting adenine nucleotide translocase-2Systematic analysis of off-target effects in an RNAi screen reveals microRNAs affecting sensitivity to TRAIL-induced apoptosisc-E10 is a caspase-recruiting domain-containing protein that interacts with components of death receptors signaling pathway and activates nuclear factor-kappaBInhibition of vacuolar ATPase attenuates the TRAIL-induced activation of caspase-8 and modulates the trafficking of TRAIL receptosomesModulation of the CD95-induced apoptosis: the role of CD95 N-glycosylationCaspase-2 primes cancer cells for TRAIL-mediated apoptosis by processing procaspase-8Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAILThe functional significance of microRNA-145 in prostate cancerHGS-ETR1, a fully human TRAIL-receptor 1 monoclonal antibody, induces cell death in multiple tumour types in vitro and in vivomiR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulationDoxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenograftsIrradiation specifically sensitises solid tumour cell lines to TRAIL mediated apoptosisThe anti-tumor effect of Apo2L/TRAIL on patient pancreatic adenocarcinomas grown as xenografts in SCID miceStrains, Mechanism, and Perspective: Salmonella-Based Cancer TherapyOnto better TRAILs for cancer treatmentMolecular targets of TRAIL-sensitizing agents in colorectal cancerDeath receptor-ligand systems in cancer, cell death, and inflammationCaspase-8 as a regulator of tumor cell motilityTargeting the apoptosis pathway in hematologic malignanciesGetting TRAIL back on track for cancer therapyResponses of Nontransformed Human Hepatocytes to Conditional Expression of Full-Length Hepatitis C Virus Open Reading FrameCrystal structure of TRAIL-DR5 complex identifies a critical role of the unique frame insertion in conferring recognition specificityStructural and functional analysis of the interaction between the agonistic monoclonal antibody Apomab and the proapoptotic receptor DR5Evidence that the human death receptor 4 is regulated by activator protein 1B lymphocyte stimulator (BLyS): a therapeutic trichotomy for the treatment of B lymphocyte diseasesCellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complexTranscription initiation sites and promoter structure of the human TRAIL-R3 geneCurrent treatment for Ewing's sarcomaIG20 (MADD splice variant-5), a proapoptotic protein, interacts with DR4/DR5 and enhances TRAIL-induced apoptosis by increasing recruitment of FADD and caspase-8 to the DISCMolecular architecture of the DED chains at the DISC: regulation of procaspase-8 activation by short DED proteins c-FLIP and procaspase-8 prodomainFollowing a TRAIL: update on a ligand and its five receptorsFLIP and the death effector domain familyGeneral Sensitization of melanoma cells for TRAIL-induced apoptosis by the potassium channel inhibitor TRAM-34 depends on release of SMACER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosisTrailing TRAIL Resistance: Novel Targets for TRAIL Sensitization in Cancer CellsGinsenoside compound K sensitizes human colon cancer cells to TRAIL-induced apoptosis via autophagy-dependent and -independent DR5 upregulationFasL gene-deficient mice display a limited disruption in spermatogenesis and inhibition of mono-(2-ethylhexyl) phthalate-induced germ cell apoptosisNFATc1 regulation of TRAIL expression in human intestinal cellsThe antidiabetic drug ciglitazone induces high grade bladder cancer cells apoptosis through the up-regulation of TRAILInterferon-alpha subtype 11 activates NK cells and enables control of retroviral infection
P2860
Q21133690-FC9E9FEA-73FC-42B6-BFF6-2519900E6DE2Q21267232-364E0F5A-106B-475F-9262-E924FEAF42EFQ22010238-432C875D-8EF7-406C-AD9D-DA864A7AA6A0Q24292952-FFB00C9A-02F1-44D4-BFF8-A03486CA513FQ24305009-1C65FD25-D829-47A0-8677-798EDFB3FDC8Q24337211-75B2A0B3-C60C-4498-BB51-81F79A6E85D7Q24554360-7F3CCF6A-79C2-4F7C-8A5D-6E9F84FC3574Q24606503-42793B1C-5C8E-43F5-8A27-6202184A7AD6Q24650617-B22A3F62-0265-466B-8E83-3100DB25CF4AQ24655473-C2D38D1E-799C-4322-9783-9779352EC993Q24793079-6D81E770-3067-4EA7-B74B-6962C89B0D70Q24798681-05832035-89F8-45A6-8349-55EFF625C08DQ24811656-F3ACF23C-BA26-4494-8C06-93A4F2A86709Q26748794-06D4AEE5-6E2B-498D-A4F6-676F87187092Q26768160-C0900515-FC48-4AE9-98AE-2691A384CE19Q26822382-DDBB0C34-0933-4247-A4E8-573A9A96A52BQ26865568-C2CCA5FB-5AAE-4A52-B58E-0473EC849970Q26996626-240B2422-4EB8-41A9-BAAE-CC521B71081BQ27024422-4A7D1840-8FCF-4DE7-B22A-F2D527C7E5CDQ27027460-A920401F-5572-42E8-AD4B-EE6CB0F65F8DQ27482327-05ED4930-EC4F-4C08-B0A7-D989B2E3F701Q27625357-6D198D2D-A327-4A23-9684-A96D455BA84CQ27649718-A55F5EEC-AC7D-4E99-8895-D9C881E5A730Q28206926-2535A5DC-DCAC-4B26-B09D-4C473DF469ABQ28208717-E492F646-592E-4B85-8B97-A2FBDD79C994Q28209029-780B73D1-F27D-41B4-8CDB-FD90C54904D9Q28213507-87029C2F-0C2B-4157-A3D3-8D9F276AC34CQ28248896-A91B5172-144F-4B47-A669-7D43A6683540Q28267857-8EDC446E-1A97-4F26-A0BC-C47459FA9FB1Q28268989-3E3811CE-643A-4C19-957B-5469FF643570Q28292767-250CA460-4ED9-4057-958D-286ACD520601Q28297969-A1C431BF-558E-4424-B390-0D0D080FBAE0Q28385542-34B9D15D-A349-43A0-9EFF-B400957B389EQ28386923-4D4B57C8-C760-4372-ABFD-D3C9DFBC9DFCQ28391040-9535B2D3-777C-42A4-8FE2-86DCDF7DDD7EQ28394059-4593AA0C-6164-4D8D-9A27-81BCDD91FE2EQ28394309-9D7720F9-602B-4904-B467-C9632ADF0C3AQ28478149-1474C944-24E5-41A1-80C0-2160FAB49704Q28478349-97247FEC-5D7D-46BD-A49B-018ED6F007FFQ28482160-8A63D886-899B-4767-ABC9-157BEC99F825
P2860
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.
@en
type
label
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.
@en
prefLabel
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.
@en
P2093
P356
P1433
P1476
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo
@en
P2093
Goodwin RG
Griffith TS
P2888
P304
P356
10.1038/5517
P407
P50
P577
1999-02-01T00:00:00Z